A multiple dose, dose-finding, placebo controlled, double blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and evaluate the efficacy, safety, and tolerability of MDCO-216 given as multiple weekly infusions in subjects with a recent acute coronary syndrome event

Trial Profile

A multiple dose, dose-finding, placebo controlled, double blind, randomized trial to compare the effect of treatment on plaque burden as determined by intravascular ultrasound and evaluate the efficacy, safety, and tolerability of MDCO-216 given as multiple weekly infusions in subjects with a recent acute coronary syndrome event

Recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs MDCO 216 (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms MILANO DRIVE
  • Sponsors The Medicines Company
  • Most Recent Events

    • 27 Nov 2016 This trial has been discontinued in Hungary, according to European Clinical Trials Database record.
    • 04 Nov 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top